| HLA-B |
P01889
|
major histocompatibility complex, class I, B
|
|
3.9E-05 |
0.379 |
0.885 |
| CYP21A2 |
P08686
|
cytochrome P450 family 21 subfamily A member 2
|
|
2.6E-04 |
0.525 |
0.769 |
| HLA-A |
P04439
|
major histocompatibility complex, class I, A
|
|
1.3E-03 |
0.370 |
0.846 |
| TSBP1-AS1 |
|
TSBP1 and BTNL2 antisense RNA 1
|
|
|
0.638 |
0.692 |
| FOXP1 |
Q9H334
|
forkhead box P1
|
|
1.00 |
0.460 |
0.808 |
| HFE |
Q30201
|
homeostatic iron regulator
|
|
2.6E-08 |
0.436 |
0.846 |
| MAPT |
P10636
|
microtubule associated protein tau
|
|
6.0E-03 |
0.446 |
0.923 |
| RERE |
Q9P2R6
|
arginine-glutamic acid dipeptide repeats
|
|
1.00 |
0.526 |
0.846 |
| NOTCH4 |
Q99466
|
notch receptor 4
|
|
2.1E-23 |
0.534 |
0.731 |
| CSMD1 |
Q96PZ7
|
CUB and Sushi multiple domains 1
|
|
1.00 |
0.610 |
0.500 |
| PSORS1C1 |
Q9UIG5
|
psoriasis susceptibility 1 candidate 1
|
|
2.7E-04 |
0.656 |
0.731 |
| KANSL1 |
Q7Z3B3
|
KAT8 regulatory NSL complex subunit 1
|
|
1.00 |
0.592 |
0.731 |
| TNXB |
P22105
|
tenascin XB
|
|
1.9E-02 |
0.572 |
0.731 |
| MAD1L1 |
Q9Y6D9
|
mitotic arrest deficient 1 like 1
|
|
6.8E-16 |
0.570 |
0.731 |
| HCP5 |
Q6MZN7
|
HLA complex P5
|
|
|
0.595 |
0.808 |
| FHIT |
P49789
|
fragile histidine triad diadenosine triphosphatase
|
|
5.7E-03 |
0.444 |
0.846 |
| TSBP1 |
Q5SRN2
|
testis expressed basic protein 1
|
|
1.5E-16 |
0.638 |
0.692 |
| C2 |
P06681
|
complement C2
|
|
1.3E-16 |
0.617 |
0.692 |
| ANK3 |
Q12955
|
ankyrin 3
|
|
1.00 |
0.578 |
0.654 |
| HLA-DRB9 |
|
major histocompatibility complex, class II, DR beta 9 (pseudogene)
|
|
|
0.682 |
0.654 |
| CNNM2 |
Q9H8M5
|
cyclin and CBS domain divalent metal cation transport mediator 2
|
|
1.00 |
0.641 |
0.346 |
| BORCS7-ASMT |
|
BORCS7-ASMT readthrough (NMD candidate)
|
|
|
0.805 |
0.154 |
| MACROD2 |
A1Z1Q3
|
mono-ADP ribosylhydrolase 2
|
|
0.43 |
0.686 |
0.423 |
| MEF2C-AS1 |
|
MEF2C antisense RNA 1
|
|
|
0.861 |
0.154 |
| TRIM31 |
Q9BZY9
|
tripartite motif containing 31
|
|
4.3E-06 |
0.626 |
0.577 |